Emerald Mutual Fund Advisers Trust’s Aegerion Pharmaceuticals AEGR Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-87,132	Closed	-$5.42M	–	246
2013 Q4	$5.42M	Buy	87,132 +30,815	+55%	+$2.36M	0.32%	98
2013 Q3	$4.83M	Sell	56,317 -5,460	-9%	-$463K	0.67%	60
2013 Q2	$3.91M	Buy	+61,777	New	+$3.28M	0.66%	59

Other funds holding AEGR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's AEGR Position: Q1 2014 in Review

Emerald Mutual Fund Advisers Trust sold out of Aegerion Pharmaceuticals (AEGR) in Q1 2014, closing a stake of 87,132 shares — an estimated $5.42M sold.

Emerald Mutual Fund Advisers Trust first reported a position in AEGR in Q2 2013 and held it in 3 quarters. The position peaked at $5.42M in Q4 2013. 131 funds tracked by Wall St. Rank hold AEGR as of Q1 2014.

Emerald Mutual Fund Advisers Trust reported no remaining Aegerion Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 87,132 Aegerion Pharmaceuticals shares in Q1 2014, an estimated $5.42M.
Emerald Mutual Fund Advisers Trust first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 3 quarters.
Emerald Mutual Fund Advisers Trust's Aegerion Pharmaceuticals position peaked at $5.42M in Q4 2013.
131 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q1 2014.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2014, filed 30 Apr 2014.